Effects of Osteopathic Manipulative Treatment on Diabetic Gastroparesis.

Use of case-based reasoning to enhance intensive management of patients on insulin pump therapy. J Diabetes Sci Technol (2008) 1.26

Evaluating the automated blood glucose pattern detection and case-retrieval modules of the 4 Diabetes Support System. J Diabetes Sci Technol (2010) 1.05

Characterizing blood glucose variability using new metrics with continuous glucose monitoring data. J Diabetes Sci Technol (2011) 0.98

Type 2 diabetes mellitus: practical approaches for primary care physicians. J Am Osteopath Assoc (2011) 0.89

Relationship between type-2 diabetes and use of metformin with risk of colorectal adenoma in an American population receiving colonoscopy. J Diabetes Complications (2013) 0.88

A consensus perceived glycemic variability metric. J Diabetes Sci Technol (2013) 0.86

Racial disparities in African Americans with diabetes: process and outcome mismatch. Am J Manag Care (2012) 0.83

Diabetes care in extended-care facilities: appropriate intensity of care? Diabetes Care (2007) 0.82

Analysis of use of an automated bolus calculator reduces fear of hypoglycemia and improves confidence in dosage accuracy in type 1 diabetes mellitus patients treated with multiple daily insulin injections. J Diabetes Sci Technol (2012) 0.80

Treatment of specific macrovascular beds in patients with diabetes mellitus. Osteopath Med Prim Care (2010) 0.79

Diabetes numeracy and blood glucose control: association with type of diabetes and source of care. Clin Diabetes (2014) 0.79

Evaluation of diabetes management in a rural community hospital. Endocr Pract (2008) 0.79

Evolution of "the guideline advantage": lessons learned from the front lines of outpatient performance measurement. Circ Cardiovasc Qual Outcomes (2014) 0.78

Use of and attitudes toward complementary and alternative medicine among osteopathic medical students. J Am Osteopath Assoc (2012) 0.78

How well are we managing diabetes in long-term care? J Fam Pract (2012) 0.78

Evolution of "the guideline advantage": lessons learned from the front lines of outpatient performance measurement. Diabetes Care (2014) 0.76

Highlights From the American Diabetes Association's 2017 Standards of Medical Care in Diabetes for Osteopathic Physicians. J Am Osteopath Assoc (2017) 0.75

Employer-Funded Complete Health Improvement Program: Preliminary Results of Biomarker Changes. J Am Osteopath Assoc (2017) 0.75

Diabetes management within evolving health care delivery models: the osteopathic perspective. J Am Osteopath Assoc (2015) 0.75

Evolution of "The Guideline Advantage": Lessons learned from the front lines of outpatient performance measurement. CA Cancer J Clin (2014) 0.75

Optimizing treatment for patients with diabetes mellitus: glycemic and nonglycemic effects. J Am Osteopath Assoc (2011) 0.75

Payer source influence on effectiveness of lifestyle medicine programs. Am J Manag Care (2015) 0.75

Vitamin D Deficiency, Its Role in Health and Disease, and Current Supplementation Recommendations. J Am Osteopath Assoc (2017) 0.75

Role of osteopathic structural diagnosis and osteopathic manipulative treatment for diabetes mellitus and its complications. J Am Osteopath Assoc (2013) 0.75

Inpatient osteopathic structural examinations: is "red tape" getting in the way of personalized patient care? J Am Osteopath Assoc (2008) 0.75

Be a "great physician" for your patients with type 2 diabetes mellitus. J Am Osteopath Assoc (2012) 0.75

Effectiveness of the Complete Health Improvement Program in Reducing Risk Factors for Cardiovascular Disease in an Appalachian Population. J Am Osteopath Assoc (2016) 0.75

Cardiovascular Disease Risk Factors After an Employer-Based Risk Reduction Program: An Observational Cohort Study. J Am Osteopath Assoc (2017) 0.75

Glycated Hemoglobin Testing to Identify Undiagnosed Diabetes Mellitus in the Inpatient Setting. J Am Osteopath Assoc (2016) 0.75

Leveraging the principles of osteopathic medicine to improve diabetes outcomes within a new era of health care reform. J Am Osteopath Assoc (2015) 0.75

GLP-1 agonists: improving the future of patients with type 2 diabetes. J Am Osteopath Assoc (2011) 0.75